单位(元)广发医疗保健股票C(009163)利润表 |
报告期 |
2022/6/30 |
2021/12/31 |
2021/6/30 |
2020/12/31 |
收入 |
-2,030,079,587 |
-822,762,830 |
2,816,003,872 |
5,529,470,283 |
利息收入 |
1,701,656 |
3,457,787 |
1,686,113 |
3,243,352 |
其中:存款利息收入 |
1,701,656 |
3,411,918 |
1,685,377 |
3,235,910 |
债券利息收入 |
- |
14,396 |
737 |
7,441 |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
31,472 |
- |
- |
投资收益 |
-1,397,697,900 |
1,541,848,168 |
1,016,528,009 |
1,868,927,657 |
其中:股票投资收益 |
-1,424,976,523 |
1,505,005,183 |
983,160,541 |
1,831,155,179 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
- |
1,249,772 |
124,133 |
11,017,384 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
27,278,623 |
35,593,213 |
33,243,335 |
26,755,094 |
公允价值变动收益 |
-644,025,573 |
-2,435,880,324 |
1,757,508,018 |
3,512,017,932 |
汇兑收益 |
- |
- |
- |
- |
其他收入 |
9,942,231 |
67,811,538 |
40,281,731 |
145,281,342 |
费用 |
101,201,296 |
271,779,329 |
129,287,096 |
212,029,065 |
管理人报酬 |
83,691,463 |
198,811,402 |
97,319,446 |
144,285,066 |
托管费 |
13,948,577 |
33,135,234 |
16,219,908 |
24,047,511 |
销售服务费 |
3,429,149 |
5,332,882 |
2,303,482 |
3,415,063 |
交易费用 |
- |
34,224,239 |
13,313,292 |
40,002,855 |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
132,107 |
275,568 |
130,965 |
278,542 |
利润总额 |
-2,131,280,883 |
-1,094,542,160 |
2,686,716,776 |
5,317,441,218 |
减:所得税费用 |
- |
- |
- |
- |
净利润 |
-2,131,280,883 |
-1,094,542,160 |
2,686,716,776 |
5,317,441,218 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。